Table 3.
The association of 1 standard deviation increment in eicosapentaenoic acid/arachidonic acid, docosahexaenoic acid/arachidonic acid, eicosapentaenoic acid (%), docosahexaenoic acid (%) and arachidonic acid (%) with log‐transformed serum resistin level
| Age‐ and sex‐adjusted | P‐value | Model 1 | P‐value | Model 1 + HOMA‐IR | P‐value | |
|---|---|---|---|---|---|---|
| β (95% CI) per 1 SD increment in log‐transformed EPA/AA | −0.06 (−0.08 to −0.04) | <0.001 | −0.03 (−0.05 to −0.01) | <0.001 | −0.03 (−0.05 to −0.01) | <0.001 |
| β (95% CI) per 1 SD increment in log‐transformed DHA/AA | −0.05 (−0.07 to −0.03) | <0.001 | −0.02 (−0.04 to −0.01) | 0.009 | −0.02 (−0.04 to −0.01) | 0.01 |
| β (95% CI) per 1 SD increment in log‐transformed EPA (%) | −0.07 (−0.09 to −0.06) | <0.001 | −0.04 (−0.06 to −0.02) | <0.001 | −0.04 (−0.06 to −0.02) | <0.001 |
| β (95% CI) per 1 SD increment in log‐transformed DHA (%) | −0.08 (−0.1 to −0.07) | <0.001 | −0.04 (−0.06 to −0.02) | <0.001 | −0.04 (−0.06 to −0.02) | <0.001 |
| β (95% CI) per 1 SD increment in AA (%) | −0.03 (−0.05 to −0.012) | 0.001 | −0.02 (−0.04 to −0.001) | 0.04 | −0.01 (−0.04 to −0.002) | 0.03 |
The proportions of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) or arachidonic acid (AA) in total free fatty acid were defined as EPA (%), DHA (%) and AA (%), respectively. Model 1 includes age, sex, estimated glomerular filtration rate, body mass index, white blood cell count, total energy intake, current smoking, current drinking and regular exercise. CI, confidence interval; FA, fatty acid; HOMA‐IR, homeostasis model assessment of insulin resistance; SD, standard deviation.